Evidence map›Paper›PMID 31740442›Full record

ArticleDiabetes2020

Mitochondrial Proton Leak Regulated by Cyclophilin D Elevates Insulin Secretion in Islets at Nonstimulatory Glucose Levels.

Evan P Taddeo, Nour Alsabeeh, Siyouneh Baghdasarian, Jakob D Wikstrom, Eleni Ritou, Samuel Sereda, Karel Erion, Jin Li, Linsey Stiles, Muhamad Abdulla and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Evan P TaddeoDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Nour AlsabeehDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Siyouneh BaghdasarianDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Jakob D WikstromDermatology and Venereology Unit, Department of Medicine, Karolinska Institutet, and Department of Dermato-Venereology, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-4287-1774
Eleni RitouDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Samuel SeredaEndocrinology, Diabetes, Nutrition and Weight Management Section, Department of Medicine, Boston University School of Medicine, Boston, MA.
Karel ErionDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Jin LiDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Linsey StilesDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Muhamad AbdullaDepartment of Surgery and Schulze Diabetes Institute, University of Minnesota School of Medicine, Minneapolis, MN.
Zachary SwansonDepartment of Surgery and Schulze Diabetes Institute, University of Minnesota School of Medicine, Minneapolis, MN.
Joshua J WilhelmDepartment of Surgery and Schulze Diabetes Institute, University of Minnesota School of Medicine, Minneapolis, MN.
Melena D BellinDepartment of Surgery and Schulze Diabetes Institute, University of Minnesota School of Medicine, Minneapolis, MN.
Richard G KibbeyDepartments of Internal Medicine (Endocrinology) and Cellular & Molecular Physiology, Yale University, New Haven, CT.
Marc LiesaDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA mliesa@mednet.ucla.edu oshirihai@mednet.ucla.edu.ORCID 0000-0002-5909-8570
Orian S ShirihaiDivision of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA mliesa@mednet.ucla.edu oshirihai@mednet.ucla.edu.ORCID 0000-0001-8466-3431
University of California, Los Angeles · USUniversity of Minnesota · USBoston University · USKarolinska University Hospital · SEYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
Mitochondrial dynamics in beta cell function and dysfunctionR01DK074778 · NIDDK · TUFTS UNIVERSITY BOSTON · PI CORKEY, BARBARA E., SHIRIHAI, ORIAN S · 2007 to 2015
$3.5M
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue MetabolismR01DK108283 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G, MASON, GRAEME F. · 2016 to 2019
$2.1M
Mitochondrial regulation of energy efficiencyR01DK099618 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CORKEY, BARBARA E., SHIRIHAI, ORIAN S · 2014 to 2018
$1.8M
Chastening the double-edged sword of glucose metabolism in beta-cellsR01DK110181 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G · 2016 to 2019
$1.7M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK074778NIDDK NIH HHS R01 DK099618NIDDK NIH HHS R01 DK108283NIDDK NIH HHS R01 DK110181
6 · The paper itself

Abstract

Fasting hyperinsulinemia precedes the development of type 2 diabetes. However, it is unclear whether fasting insulin hypersecretion is a primary driver of insulin resistance or a consequence of the progressive increase in fasting glycemia induced by insulin resistance in the prediabetic state. Herein, we have discovered a mechanism that specifically regulates non-glucose-stimulated insulin secretion (NGSIS) in pancreatic islets that is activated by nonesterified free fatty acids, the major fuel used by β-cells during fasting. We show that the mitochondrial permeability transition pore regulator cyclophilin D (CypD) promotes NGSIS, but not glucose-stimulated insulin secretion, by increasing mitochondrial proton leak. Islets from prediabetic obese mice show significantly higher CypD-dependent proton leak and NGSIS compared with lean mice. Proton leak-mediated NGSIS is conserved in human islets and is stimulated by exposure to nonesterified free fatty acids at concentrations observed in obese subjects. Mechanistically, proton leak activates islet NGSIS independently of mitochondrial ATP synthesis but ultimately requires closure of the K

Indexed as

AnimalsBlood GlucoseCyclophilinsDiet, High-FatFatty Acids, NonesterifiedGene Expression RegulationHumansInsulinInsulin SecretionIslets of LangerhansMiceMice, Inbred C57BLMice, KnockoutMitochondriaOleic AcidOxygen ConsumptionBlood GlucoseCyclophilinsFatty Acids, NonesterifiedInsulinOleic AcidPalmitic AcidPeptidyl-Prolyl Isomerase DPeptidyl-Prolyl Isomerase FPPID protein, humanProtons

Identifiers

PMID31740442
PMCPMC6971491
OpenAlexW2991009165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.